CFO appointment
Niki BioSolutions, Inc. appoints Thomas Freeburg as CFO
Niki BioSolutions, Inc. reported in a Form 8-K filed October 13, 2026 that Thomas Freeburg was appointed Chief Financial Officer, effective September 1, 2026.
In the filing's words
On October 9, 2026, the Board of Directors (the “Board”) of Niki BioSolutions, Inc., a Delaware corporation (the “Company”), appointed Thomas Freeburg as the Chief Financial Officer, to serve at the discretion of the Board, for a period of two years, commencing as of September 1, 2026, unless terminated sooner by either party.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Niki BioSolutions, Inc. (NIKI) |
|---|---|
| Event | Appointment |
| Incoming | Thomas Freeburg |
| Title in the filing | Chief Financial Officer |
| Effective | September 1, 2026 |
| 8-K filed | October 13, 2026 |
| Internal promotion | No |
| Prior role (per filing) | Managing Member, Cambridge Accounting Group, LLC |
| SEC CIK | 0001734005 |
Niki BioSolutions, Inc. reported this change in a Form 8-K, Item 5.02, filed October 13, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-10-14
Something wrong about Thomas Freeburg? Send a correction with the primary source.